» Articles » PMID: 36426750

Duration and Characteristics of Persistent Headache Following Aneurysmal Subarachnoid Hemorrhage

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2022 Nov 25
PMID 36426750
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the long-term frequency, prognosis, and phenotype of persistent headache following aneurysmal subarachnoid hemorrhage (aSAH).

Background: Very little is known about long-term headache following aSAH with no studies looking beyond 3 years.

Methods: Retrospective analysis comparing aSAH cases to matched controls in the UK Biobank, a prospective cohort study. Headache frequency and phenotype were compared using group comparison tests. The relationship between headache frequency and time was assessed using correlation analysis.

Results: Headache was more frequent following aSAH (aSAH: 258/864 [29.9%] vs. controls: 666/3456 [19.3%], χ  = 45.5, p < 0.001) at a median follow-up of 7.5 years. Headache frequency decreased over time (R  = -0.71, p = 0.028), affecting 29/58 (50%) patients in the first year and reducing to 13/47 (28%) patients 10 years later. Headache frequency was not related to aSAH severity (z = 0.249, p = 0.803), treatment (z = 0.583, p = 0.560), or hydrocephalus (z = -1.244, p = 0.214). There was a consistently higher frequency of migrainous features following aSAH compared to controls, although this did not reach statistical significance.

Conclusions: Persistent headache is more frequent following aSAH compared to controls in the long term and the prevalence reduces gradually over time. The increased frequency of migrainous features suggests that selected patients with post-aSAH headache may benefit from migraine treatment.

Citing Articles

Erenumab in a patient with persistent headaches after subarachnoid hemorrhage: A case report of an effective treatment.

Gandhi A, Quinoa T, Geller E, Khandelwal P, Agarwalla P Headache. 2025; 65(2):373-376.

PMID: 39865710 PMC: 11794963. DOI: 10.1111/head.14884.


Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage.

Gaastra B, Carmichael H, Galea I, Bulters D Headache. 2022; 62(10):1376-1382.

PMID: 36426750 PMC: 10099612. DOI: 10.1111/head.14418.

References
1.
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

2.
Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R . Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010; 30(26):8807-14. PMC: 2907647. DOI: 10.1523/JNEUROSCI.0511-10.2010. View

3.
Calabrese L, Dodick D, Schwedt T, Singhal A . Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007; 146(1):34-44. DOI: 10.7326/0003-4819-146-1-200701020-00007. View

4.
Gaastra B, Carmichael H, Galea I, Bulters D . Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage. Headache. 2022; 62(10):1376-1382. PMC: 10099612. DOI: 10.1111/head.14418. View

5.
Glisic E, Gardiner L, Josti L, Dermanelian E, Ridel S, Dziodzio J . Inadequacy of Headache Management After Subarachnoid Hemorrhage. Am J Crit Care. 2016; 25(2):136-43. DOI: 10.4037/ajcc2016486. View